Abetimus sodiumProduct ingredient for Abetimus
- Name
- Abetimus sodium
- Drug Entry
- Abetimus
Abetimus was developed by La Jolla Pharmaceuticals as an immunosuppressant but was never marketed in American or Europe despite application for marketing authorization in the mid-2000s.
- Accession Number
- DBSALT002035
- Synonyms
- Abetimus sodium
- External IDs
- LJP 394 / LJP-394
- UNII
- F5Y7739G6U
- CAS Number
- 169147-32-4
- External Links
- KEGG Drug
- D03204